Tanaka et al. studied HER2 overexpression in the rare skin condition extramammary Paget’s disease (EMPD), demonstrating that HER2 is overexpressed in aggressive EMPD cases with lymph node metastasis. This evidence concerns the gene ERBB2 and extramammary Paget disease.